tiprankstipranks
Rezolute, Inc. (RZLT)
NASDAQ:RZLT
US Market
RZLT
Rezolute
RESEARCH TOOLSreports
Want to see RZLT full AI Analyst Report?

Rezolute (RZLT) Stock Forecast & Price Target

750 Followers
See the Price Targets and Ratings of:

RZLT Analyst Ratings

Strong Buy
8Ratings
Strong Buy
6 Buy
2 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Rezolute
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RZLT Stock 12 Month Forecast

Average Price Target

$8.00
▲(131.21% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Rezolute in the last 3 months. The average price target is $8.00 with a high forecast of $14.00 and a low forecast of $5.00. The average price target represents a 131.21% change from the last price of $3.46.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","8":"$8","15":"$15","4.5":"$4.5","11.5":"$11.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$14.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,4.5,8,11.5,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.61,4.409230769230769,5.208461538461538,6.007692307692308,6.806923076923077,7.6061538461538465,8.405384615384616,9.204615384615385,10.003846153846155,10.803076923076924,11.602307692307694,12.401538461538461,13.20076923076923,{"y":14,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.61,3.9476923076923076,4.285384615384615,4.623076923076923,4.96076923076923,5.298461538461538,5.636153846153846,5.973846153846154,6.311538461538461,6.649230769230769,6.986923076923077,7.3246153846153845,7.662307692307692,{"y":8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.61,3.7169230769230768,3.8238461538461537,3.9307692307692306,4.037692307692308,4.144615384615385,4.251538461538462,4.358461538461539,4.4653846153846155,4.572307692307692,4.679230769230769,4.786153846153846,4.893076923076923,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.225,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.42,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.87,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.17,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.43,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.32,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.17,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.36,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.24,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.14,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.13,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.3,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.61,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$14.00Average Price Target$8.00Lowest Price Target$5.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on RZLT
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$5
Buy
44.51%
Upside
Reiterated
06/03/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citizens JMP Analyst forecast on RZLT
Jason Butler
Citizens JMP
Citizens JMP
$11
Buy
217.92%
Upside
Upgraded
06/03/26
Rezolute upgraded to Outperform from Market Perform at CitizensRezolute upgraded to Outperform from Market Perform at Citizens
Guggenheim Analyst forecast on RZLT
Debjit Chattopadhyay
Guggenheim
Guggenheim
$6
Buy
73.41%
Upside
Reiterated
06/03/26
Rezolute (RZLT) Receives a Buy from Guggenheim
Wedbush Analyst forecast on RZLT
Yun Zhong
Wedbush
Wedbush
$5→$6
Buy
73.41%
Upside
Assigned
06/03/26
Analysts Are Bullish on These Healthcare Stocks: Rezolute (RZLT), Relay Therapeutics (RLAY)
Maxim Group Analyst forecast on RZLT
Jason McCarthy
Maxim Group
Maxim Group
$10→$14
Buy
304.62%
Upside
Assigned
06/03/26
Rezolute price target raised to $14 from $10 at MaximRezolute price target raised to $14 from $10 at Maxim
BTIG Analyst forecast on RZLT
Julian Harrison
BTIG
BTIG
$5→$6
Buy
73.41%
Upside
Reiterated
06/02/26
Rezolute price target raised to $6 from $5 at BTIGRezolute price target raised to $6 from $5 at BTIG
Cantor Fitzgerald Analyst forecast on RZLT
Pete Stavropoulos
Cantor Fitzgerald
Cantor Fitzgerald
―
Hold
―
Reiterated
03/25/26
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), Rezolute (NASDAQ: RZLT) and Demant (Other OTC: WILLF)
Craig-Hallum Analyst forecast on RZLT
Matt Hewitt
Craig-Hallum
Craig-Hallum
―
Hold
―
Assigned
03/24/26
Analysts Conflicted on These Healthcare Names: Rezolute (NASDAQ: RZLT), Celcuity (NASDAQ: CELC) and Neurogene (NASDAQ: NGNE)
Jefferies Analyst forecast on RZLT
Maury Raycroft
Jefferies
Jefferies
$15→$20
Buy
478.03%
Upside
Reiterated
12/08/25
Rezolute price target raised to $20 from $15 at JefferiesRezolute price target raised to $20 from $15 at Jefferies
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on RZLT
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$5
Buy
44.51%
Upside
Reiterated
06/03/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citizens JMP Analyst forecast on RZLT
Jason Butler
Citizens JMP
Citizens JMP
$11
Buy
217.92%
Upside
Upgraded
06/03/26
Rezolute upgraded to Outperform from Market Perform at CitizensRezolute upgraded to Outperform from Market Perform at Citizens
Guggenheim Analyst forecast on RZLT
Debjit Chattopadhyay
Guggenheim
Guggenheim
$6
Buy
73.41%
Upside
Reiterated
06/03/26
Rezolute (RZLT) Receives a Buy from Guggenheim
Wedbush Analyst forecast on RZLT
Yun Zhong
Wedbush
Wedbush
$5→$6
Buy
73.41%
Upside
Assigned
06/03/26
Analysts Are Bullish on These Healthcare Stocks: Rezolute (RZLT), Relay Therapeutics (RLAY)
Maxim Group Analyst forecast on RZLT
Jason McCarthy
Maxim Group
Maxim Group
$10→$14
Buy
304.62%
Upside
Assigned
06/03/26
Rezolute price target raised to $14 from $10 at MaximRezolute price target raised to $14 from $10 at Maxim
BTIG Analyst forecast on RZLT
Julian Harrison
BTIG
BTIG
$5→$6
Buy
73.41%
Upside
Reiterated
06/02/26
Rezolute price target raised to $6 from $5 at BTIGRezolute price target raised to $6 from $5 at BTIG
Cantor Fitzgerald Analyst forecast on RZLT
Pete Stavropoulos
Cantor Fitzgerald
Cantor Fitzgerald
―
Hold
―
Reiterated
03/25/26
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), Rezolute (NASDAQ: RZLT) and Demant (Other OTC: WILLF)
Craig-Hallum Analyst forecast on RZLT
Matt Hewitt
Craig-Hallum
Craig-Hallum
―
Hold
―
Assigned
03/24/26
Analysts Conflicted on These Healthcare Names: Rezolute (NASDAQ: RZLT), Celcuity (NASDAQ: CELC) and Neurogene (NASDAQ: NGNE)
Jefferies Analyst forecast on RZLT
Maury Raycroft
Jefferies
Jefferies
$15→$20
Buy
478.03%
Upside
Reiterated
12/08/25
Rezolute price target raised to $20 from $15 at JefferiesRezolute price target raised to $20 from $15 at Jefferies
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Rezolute

3 Months
Julian HarrisonBTIG
Success Rate
8/13 ratings generated profit
62%
Average Return
+23.61%
Copying Julian Harrison's trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +23.61% per trade.
1 Year
Douglas TsaoH.C. Wainwright
Success Rate
15/21 ratings generated profit
71%
Average Return
+86.38%
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +86.38% per trade.
2 Years
Douglas TsaoH.C. Wainwright
Success Rate
15/21 ratings generated profit
71%
Average Return
+95.87%
Copying Douglas Tsao's trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +95.87% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RZLT Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
9
7
4
8
7
Buy
2
2
2
0
3
Hold
7
5
4
2
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
14
10
10
10
In the current month, RZLT has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RZLT average Analyst price target in the past 3 months is 8.00.
Each month's total comprises the sum of three months' worth of ratings.

RZLT Financial Forecast

RZLT Earnings Forecast

Next quarter’s earnings estimate for RZLT is -$0.15 with a range of -$0.20 to -$0.11. The previous quarter’s EPS was -$0.16. RZLT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year RZLT has Performed in-line its overall industry.
Next quarter’s earnings estimate for RZLT is -$0.15 with a range of -$0.20 to -$0.11. The previous quarter’s EPS was -$0.16. RZLT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year RZLT has Performed in-line its overall industry.
No data currently available

RZLT Sales Forecast

Next quarter’s sales forecast for RZLT is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. RZLT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year RZLT has Performed in-line its overall industry.
Next quarter’s sales forecast for RZLT is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. RZLT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year RZLT has Performed in-line its overall industry.

RZLT Stock Forecast FAQ

What is RZLT’s average 12-month price target, according to analysts?
Based on analyst ratings, Rezolute, Inc.’s 12-month average price target is 8.00.
    What is RZLT’s upside potential, based on the analysts’ average price target?
    Rezolute, Inc. has 131.21% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is RZLT a Buy, Sell or Hold?
          Rezolute, Inc. has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Rezolute, Inc.’s price target?
            The average price target for Rezolute, Inc. is 8.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $14.00 ,the lowest forecast is $5.00. The average price target represents 131.21% Increase from the current price of $3.46.
              What do analysts say about Rezolute, Inc.?
              Rezolute, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of RZLT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.